These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 225904)

  • 21. [A study of crystallization on urolithiasis in vitro].
    Miyazawa K; Suzuki K; Tsugawa R
    Hinyokika Kiyo; 1991 Oct; 37(10):1091-6. PubMed ID: 1721765
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Studies on mechanisms of calcification. I. Properties of urinary derivatives which inhibit cartilage calcification. II. Electron microscopic observations of the effect of inhibitors in crystal formation.
    Barker LM; McPhillips JJ; Lawrence GD; Doty SB; Pallante SL; Bills CE; Scott WW; Howard JE
    Johns Hopkins Med J; 1970 Jul; 127(1):2-22. PubMed ID: 4097235
    [No Abstract]   [Full Text] [Related]  

  • 23. A contribution to the formation mechanism of calcium oxalate urinary calculi. III. On the role of magnesium in the formation of oxalate calculi.
    Berg W; Hesse A; Schneider HJ
    Urol Res; 1976; 4(4):161-7. PubMed ID: 14432
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Studies on urinary calcium ion activity in urolithiasis, 2. The relationship to calcium oxalate crystal formation and the effects of magnesium and citrate].
    Morimoto S
    Nihon Hinyokika Gakkai Zasshi; 1985 Jul; 76(7):998-1005. PubMed ID: 4079203
    [No Abstract]   [Full Text] [Related]  

  • 25. Experiences with the measurement of inhibitory activity of urine and crystallisation inhibitors by different techniques.
    Baumann JM; Wacker M
    Urol Res; 1979 Sep; 7(3):183-8. PubMed ID: 228455
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Growth of calcium oxalate crystals. II. Inhibition by natural urinary crystal growth inhibitors.
    Meyer JL; Smith LH
    Invest Urol; 1975 Jul; 13(1):36-9. PubMed ID: 166960
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Factors affecting calcium oxalate dihydrate fragmented calculi regrowth.
    Costa-Bauzá A; Perelló J; Isern B; Sanchis P; Grases F
    BMC Urol; 2006 Jul; 6():16. PubMed ID: 16822299
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Studies on the role of urinary macromolecules in urolithiasis: review of methodologies and a proposal for a standard reference crystallization system.
    Rodgers AL; Jappie D
    Scanning Microsc; 1996; 10(2):535-45; discussion 545-6. PubMed ID: 9813630
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Variations in the activity of urinary inhibitors in calcium oxalate urolithiasis.
    Grases F; Genestar C; March P; Conte A
    Br J Urol; 1988 Dec; 62(6):515-20. PubMed ID: 2851362
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Uric acid and oxalate lithiasis. Physico-chemical and crystallo-chemical explanation of the relationship].
    Leskovar P
    Z Urol Nephrol; 1980 Mar; 73(3):211-21. PubMed ID: 7434985
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Low-molecular-weight dextran sulfate prevents experimental urolithiasis in rats.
    Tostes V; Martinusso CA; Werneck CC; Mourão PA; Cardoso LR
    Clin Chim Acta; 2004 Mar; 341(1-2):147-55. PubMed ID: 14967171
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Urinary glycosaminoglycans are selectively included into calcium oxalate crystals precipitated from whole human urine.
    Suzuki K; Mayne K; Doyle IR; Ryall RL
    Scanning Microsc; 1994; 8(3):523-30. PubMed ID: 7747154
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Inhibitory effect of oral administration of Takusya on calcium oxalate crystallization in human whole urine].
    Honda M; Yoshimura K; Miyake O; Yoshioka T; Okuyama A; Yamaguchi S; Utsunomiya M; Koide T; Sugiyama K
    Hinyokika Kiyo; 1997 May; 43(5):333-7. PubMed ID: 9208316
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Independent assessment of the growth and aggregation of calcium oxalate crystals using the Coulter counter.
    Ryall RL; Bagley CJ; Marshall VR
    Invest Urol; 1981 Mar; 18(5):401-5. PubMed ID: 7203965
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Simple method for the study of heterogeneous nucleation in calcium oxalate urolithiasis.
    Grases F; Conte A; Gil JJ
    Br J Urol; 1988 Jun; 61(6):468-73. PubMed ID: 3401655
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Studies on calcium oxalate crystal formation in urolithiasis].
    Kataoka K
    Nihon Hinyokika Gakkai Zasshi; 1987 Feb; 78(2):203-17. PubMed ID: 3613329
    [No Abstract]   [Full Text] [Related]  

  • 37. Studies on urinary stone formation: a saga of clinical investigation.
    Howard JE
    Johns Hopkins Med J; 1976 Dec; 139(6):239-52. PubMed ID: 12399
    [No Abstract]   [Full Text] [Related]  

  • 38. The influence of hydroxyapatite and pyrophosphate on the formation product of calcium oxalate at different pHs.
    Baumann JM; Ackermann D; Affolter B
    Urol Res; 1989; 17(3):153-5. PubMed ID: 2546312
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibitors of crystal growth of hydroxyapatite: a constant composition approach.
    Wilson JW; Werness PG; Smith LH
    J Urol; 1985 Dec; 134(6):1255-8. PubMed ID: 2997488
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effects of glycosaminoglycans, pyrophosphate and allopurinol treatment on urease-induced crystallization in vitro.
    Hedelin H; Grenabo L; Pettersson S
    Urol Res; 1986; 14(6):305-7. PubMed ID: 3027940
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.